Xanthic Partners With ABH Pharma Inc. To Produce CBD-Infused Dietary Supplements For National U.S. Retailers And E-Commerce Customers

10:30 EDT 11 Jun 2018 | Investing News Network

Xanthic Biopharma (CSE:xTHC) is pleased to announce a strategic partnership with ABH Pharma Inc. ("ABH"), a leading FDA-registered and GMP-certified manufacturer of in-house branded and private label dietary supplements in the United States.

More From BioPortfolio on "Xanthic Partners With ABH Pharma Inc. To Produce CBD-Infused Dietary Supplements For National U.S. Retailers And E-Commerce Customers"